Edwards Lifesciences Corp (EW) Stake Increased by Montag & Caldwell Llc

September 13, 2017 - By Linda Rogers

Montag & Caldwell Llc increased its stake in Edwards Lifesciences Corp (EW) by 10690.4% based on its latest 2016Q4 regulatory filing with the SEC. Montag & Caldwell Llc bought 1.44 million shares as the company’s stock rose 25.80% with the market. The institutional investor held 1.45M shares of the industrial specialties company at the end of 2016Q4, valued at $136.27M, up from 13,478 at the end of the previous reported quarter. Montag & Caldwell Llc who had been investing in Edwards Lifesciences Corp for a number of months, seems to be bullish on the $23.60B market cap company. The stock decreased 2.54% or $2.91 during the last trading session, reaching $111.78. About 1.21 million shares traded or 0.83% up from the average. Edwards Lifesciences Corp (NYSE:EW) has risen 15.41% since September 13, 2016 and is uptrending. It has underperformed by 1.29% the S&P500.

Montag & Caldwell Llc, which manages about $14.22 billion and $4.14B US Long portfolio, decreased its stake in Visa Inc (NYSE:V) by 381,198 shares to 2.38 million shares, valued at $185.87M in 2016Q4, according to the filing. It also reduced its holding in Mastercard Inc (NYSE:MA) by 153,171 shares in the quarter, leaving it with 920,987 shares, and cut its stake in Medtronic Plc (NYSE:MDT).

More notable recent Edwards Lifesciences Corp (NYSE:EW) news were published by: Prnewswire.com which released: “Edwards Lifesciences To Present At The 12th Annual Wells Fargo Healthcare …” on August 31, 2017, also Finance.Yahoo.com with their article: “Here’s Why Investors Should Buy Edwards Lifesciences Now” published on August 17, 2017, Nasdaq.com published: “Scholtz & Company, Llc Buys Edwards Lifesciences Corp, Cotiviti Holdings Inc …” on August 14, 2017. More interesting news about Edwards Lifesciences Corp (NYSE:EW) were released by: Seekingalpha.com and their article: “Edwards Lifesciences Stock To Remain Strong Ahead Of Robust Revenue And New …” published on August 15, 2017 as well as Nasdaq.com‘s news article titled: “Why the Earnings Streak Will Continue for Edwards Lifesciences (EW)” with publication date: September 12, 2017.

Edwards Lifesciences Corp (NYSE:EW) Ratings Coverage

Among 26 analysts covering Edwards Lifesciences Corp (NYSE:EW), 20 have Buy rating, 1 Sell and 5 Hold. Therefore 77% are positive. Edwards Lifesciences Corp had 76 analyst reports since July 30, 2015 according to SRatingsIntel. Canaccord Genuity maintained Edwards Lifesciences Corp (NYSE:EW) rating on Tuesday, June 27. Canaccord Genuity has “Buy” rating and $15000 target. The firm has “Sell” rating by Citigroup given on Thursday, November 12. The stock of Edwards Lifesciences Corp (NYSE:EW) has “Buy” rating given on Friday, May 26 by Jefferies. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, February 3. The stock of Edwards Lifesciences Corp (NYSE:EW) earned “Outperform” rating by Cowen & Co on Friday, October 9. The firm earned “Buy” rating on Thursday, August 31 by BMO Capital Markets. The stock of Edwards Lifesciences Corp (NYSE:EW) has “Equal-Weight” rating given on Thursday, April 7 by Barclays Capital. The firm has “Market Perform” rating given on Tuesday, April 5 by Northland Capital. The firm has “Mkt Perform” rating by JMP Securities given on Wednesday, January 6. The firm has “Buy” rating by Canaccord Genuity given on Thursday, July 27.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: